New Data Relating to Sotagliflozin to be Presented at the American Society of Nephrology (ASN) Kidney Week 2023 Annual Meeting
Provided By GlobeNewswire
Last update: Oct 30, 2023
Presentations from four Lexicon-sponsored studies will highlight data supporting current and potential future use of sotagliflozin
INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure
Read more at globenewswire.com
